First Header Logo Second Header Logo

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

Veverka KK, Feldman SR. Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism? J Dermatolog Treat. 2018 Aug; 29(5):475-480.

View in: PubMed